Metropolitan Life Insurance Company (MetLife)’s Foghorn Therapeutics FHTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,295
| Closed | -$6.48K | – | 2362 |
|
|
2023
Q3 | $6.48K | Hold |
1,295
| – | – | ﹤0.01% | 2370 |
|
|
2023
Q2 | $9.12K | Buy |
+1,295
| New | +$9.12K | ﹤0.01% | 2340 |
|
|
2023
Q1 | – | Sell |
-1,439
| Closed | -$9.18K | – | 2363 |
|
|
2022
Q4 | $9.18K | Sell |
1,439
-181
| -11% | -$1.16K | ﹤0.01% | 2304 |
|
|
2022
Q3 | $13.9K | Hold |
1,620
| – | – | ﹤0.01% | 2188 |
|
|
2022
Q2 | $22K | Hold |
1,620
| – | – | ﹤0.01% | 2007 |
|
|
2022
Q1 | $24.7K | Sell |
1,620
-4,949
| -75% | -$75.4K | ﹤0.01% | 1994 |
|
|
2021
Q4 | $150K | Hold |
6,569
| – | – | ﹤0.01% | 2220 |
|
|
2021
Q3 | $91.5K | Buy |
+6,569
| New | +$91.5K | ﹤0.01% | 2569 |
|